4月9日 - ** 由于中国市场需求强劲，第一季度初步销售额超出预期，视力矫正镜片制造商STAAR SurgicalSTAA.O股价盘前大涨19.8%至25美元。
** 第一季度销售额为9000万美元，同比增长一倍多，分析师平均预期为7300万美元--LSEG编制的数据
** STAA 上一季度销售额未达预期
** 10家券商中有9家将该股评级为 "持有"，1家为 "卖出 "或更低评级；其中位数PT为21美元
** 截至上次收盘，STAA 年累计下跌 9.6%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.